Kisspeptin-10
Also known as: Kisspeptina-10
Molecular Identifiers
Overview
Upstream regulator of GnRH. Research in reproductive endocrinology. Highly variable dosage per study protocol.
YNWNSFGLRF Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe Half-life
~4-5 minutes
Administration Route
Subcutaneous or intravenous
Category
Hormonal Regulation
Mechanism of Action
- Stimulation of GnRH release via GPR54 receptor
- Upstream regulation of the reproductive axis
- Modulation of pulsatile LH secretion
Dosage Protocol
Data compiled from the literature. This does not constitute medical advice.
| Parameter | Value |
|---|---|
| Dose | 1-10 mcg per injection |
| Frequency | Per research protocol |
| Timing | Per study design |
| Duration | Per study |
Reported Side Effects
Adverse effects described in the literature. Severity and frequency vary between individuals.
- Facial flushing
- Headache
- Nausea
- Injection site pain
Presentations & Preparation
Vials of Kisspeptin-10 found in the research market:
Reconstitution
- Diluent: Bacteriostatic water
- Volume: 1 ml per vial
- Inject the diluent slowly against the vial wall
- Gently swirl until fully dissolved
- Never shake
Storage
- Lyophilized: -20°C
- Reconstituted: Refrigerated 2-8°C (use promptly)
- Protect from direct light
- Limited stability after reconstitution
Scientific Studies
Published studies on Kisspeptin-10.
Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men
George JT, Veldhuis JD, Roseweir AK, Newton CL, Faccenda E, Millar RP, Anderson RA
Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion
George JT, Millar RP, Anderson RA
Related Peptides
Argipressin
5-20 IU or 1-4 mcg/kg · As clinically needed
Cetrorelix
0.25-3 mg per injection · Once daily (0.25 mg) or single dose (3 mg)
Gonadorelin
100-200 mcg per injection · 2-3 times per week
HCG
250-500 IU per injection · 2-3 times per week
α-MSH
0.5-2 mg per injection · Once daily or every other day
Oxytocin
10-40 IU intranasal or 50-200 mcg subcutaneous · 1-2 times daily